glp 1 for alzheimer's GLP-1 drugs failed to slow in two big clinical trials GLP-1 medications entered mainstream conversation

Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y, Zhang Y, Zhang W

Uses & Effectiveness

MOTS-c treatment was observed to mitigate OVX-induced obesity and insulin resistance by influencing brown fat activation, reducing fat accumulation, and suppressing inflammatory responses in white adipose tissue

However, subcutaneous injection is the standard route for systemic and musculoskeletal effects, as it provides more reliable bioavailability and allows injection near the injury site

So today in this episode were going to go through what these are, you know, how they work, the prevalence of the use, and some factors to consider when, you know, thinking about this as a means to weight loss

- Sophia Davis, 35, Los Angeles, California